Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors

Assignee

• The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health Office Of Technology Transfer

Inventors

• Stephen H. Leppla (37 patents)
• Shi-Hui Liu (6 patents)
• Sarah Netzel-Arnett (3 patents)
• Henning Birkedal-Hansen (3 patents)
• Thomas Bugge (6 patents)

View full patent text on Google Patents →